Hua Hao Zhong Tian Pharmaceuticals-B (02563.HK) successfully issued 25 million shares.

The Zhitong Finance and Economics App reports that Huahao Zhongtian Pharmaceutical-B (02563.HK) has announced that the conditions set forth in the subscription agreement have been met, and delivery has been implemented on July 16, 2026, in accordance with the terms and conditions of the subscription agreement. On the delivery date, the company issued and distributed a total of 25 million subscription shares to the subscriber at a subscription price of HK$4.00 per share.